NovoCure Limited
US ˙ NasdaqGS ˙ JE00BYSS4X48

SecurityNVCR / NovoCure Limited
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership218,300 shares
Latest Disclosed Value $ 2,379,470
Engineers Gate Manager LP reports 25.07% decrease in ownership of NVCR / NovoCure Limited

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 218,300 shares of NovoCure Limited (US:NVCR) valued at $2,379,470 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 291,332 shares of NovoCure Limited. This represents a change in shares of -25.07% during the quarter. The current value of the position is $3,525,545 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVOCURE ORD SHS G6674U108 218,300 -73,032 -25.07 2,379 -36.83 0.0297
2026-02-17 2025-12-31 13F NOVOCURE ORD SHS G6674U108 291,332 18,006 6.59 3,767 6.66 0.0447
2025-11-14 2025-09-30 13F NOVOCURE ORD SHS G6674U108 273,326 -20,224 -6.89 3,531 -32.42 0.0404
2025-08-14 2025-06-30 13F NOVOCURE ORD SHS G6674U108 293,550 39,511 15.55 5,225 15.44 0.0650
2025-05-15 2025-03-31 13F NOVOCURE ORD SHS G6674U108 254,039 55,106 27.70 4,527 -23.65 0.0763
2025-02-14 2024-12-31 13F NOVOCURE ORD SHS G6674U108 198,933 -103,796 -34.29 5,928 25.30 0.1032
2024-11-14 2024-09-30 13F NOVOCURE ORD SHS G6674U108 302,729 9,866 3.37 4,732 -5.68 0.0923
2024-08-14 2024-06-30 13F NOVOCURE ORD SHS G6674U108 292,863 10,026 3.54 5,017 13.48 0.1131
2024-05-15 2024-03-31 13F NOVOCURE ORD SHS G6674U108 282,837 -49,933 -15.01 4,421 -11.03 0.1164
2024-02-14 2023-12-31 13F NOVOCURE ORD SHS G6674U108 332,770 155,982 88.23 4,968 74.01 0.1418
2023-11-14 2023-09-30 13F NOVOCURE ORD SHS G6674U108 176,788 110,417 166.36 2,855 3.67 0.1055
2023-08-14 2023-06-30 13F NOVOCURE ORD SHS G6674U108 66,371 31,543 90.57 2,754 31.52 0.1041
2023-05-15 2023-03-31 13F NOVOCURE ORD SHS G6674U108 34,828 34,828 2,095 0.0875
2022-11-14 2022-09-30 13F NOVOCURE ORD SHS G6674U108 0 -15,512 -100.00 0 -100.00
2022-08-15 2022-06-30 13F NOVOCURE ORD SHS G6674U108 15,512 3,204 26.03 1,078 5.69 0.0395
2022-05-16 2022-03-31 13F NOVOCURE ORD SHS G6674U108 12,308 -62,002 -83.44 1,020 -81.72 0.0399
2022-02-14 2021-12-31 13F NOVOCURE ORD SHS G6674U108 74,310 54,415 273.51 5,579 141.41 0.2509
2021-11-15 2021-09-30 13F NOVOCURE ORD SHS G6674U108 19,895 18,016 958.81 2,311 454.20 0.1317
2021-08-16 2021-06-30 13F NOVOCURE ORD SHS G6674U108 1,879 -4,582 -70.92 417 -51.17 0.0268
2021-05-17 2021-03-31 13F NOVOCURE ORD SHS G6674U108 6,461 -6,376 -49.67 854 -61.55 0.0423
2021-02-16 2020-12-31 13F NOVOCURE ORD SHS G6674U108 12,837 -16,937 -56.89 2,221 -32.98 0.0963
2020-11-16 2020-09-30 13F NOVOCURE ORD SHS G6674U108 29,774 10,404 53.71 3,314 188.42 0.1555
2020-08-17 2020-06-30 13F NOVOCURE ORD SHS G6674U108 19,370 -37,708 -66.06 1,149 -70.11 0.0585
2020-05-15 2020-03-31 13F NOVOCURE ORD SHS G6674U108 57,078 46,359 432.49 3,844 325.69 0.2769
2020-02-14 2019-12-31 13F NOVOCURE ORD SHS G6674U108 10,719 5,341 99.31 903 124.63 0.0397
2019-11-14 2019-09-30 13F NOVOCURE ORD SHS G6674U108 5,378 -58,127 -91.53 402 -89.99 0.0204
2019-08-14 2019-06-30 13F NOVOCURE ORD SHS G6674U108 63,505 -22,161 -25.87 4,015 -2.71 0.2216
2019-05-15 2019-03-31 13F NOVOCURE ORD SHS G6674U108 85,666 85,666 4,127 0.2499
2019-02-14 2018-12-31 13F NOVOCURE ORD SHS G6674U108 0 -5,371 -100.00 0 -100.00
2018-11-01 2018-09-30 13F NOVOCURE ORD SHS G6674U108 5,371 -54,849 -91.08 281 -85.09 0.0216
2018-08-03 2018-06-30 13F NOVOCURE ORD SHS G6674U108 60,220 60,220 1,885 0.1469
2018-05-07 2018-03-31 13F NOVOCURE ORD SHS G6674U108 0 -67,899 -100.00 0 -100.00
2018-02-01 2017-12-31 13F NOVOCURE ORD SHS G6674U108 67,899 45,438 202.30 1,372 207.62 0.0942
2017-11-13 2017-09-30 13F NOVOCURE ORD SHS G6674U108 22,461 -65,182 -74.37 446 -70.58 0.0375
2017-08-10 2017-06-30 13F NOVOCURE ORD SHS G6674U108 87,643 87,643 1,516 0.1366
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.